Clinical study for COVID-19 drug development

Biobanque 300x225

Service description

  • Implementation of a regulatory clinical phase for a new drug or repositioning for COVID-19: Phase I for toxicity, Phase IIa or IIb, measurement of efficacy and toxicity on a larger cohort, collection of PK/PD pharmacodynamic data.
  • It also applies to sample collections that require a specific protocol.
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the drug development project.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert.

Get started with your COVID-19 clinical study information request

Please answer the fields below to be contacted by our team of scientists

COVID Labtoo 60
COVID-19 Services
Samples blood 60 2
Biological Samples
R&D mecanism 60
Experimental Services
favicon large un peu plus-1